Abstract
摘要
相似文献
1
New treatment for diabetes.
FDA Consum. 2007 Jan-Feb;41(1):3.
2
[Sitagliptin].
Rev Infirm. 2008 Oct(144):46-8.
3
Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther. 2007 Jun 4;49(1262):45-7.
4
[Sitagliptine (Januvia)].
J Pharm Belg. 2008 Mar;63(1):31-2.
5
[Reply on new drugs against type 2 diabetes: important to gain experience and knowledge].
Lakartidningen. 2008;105(17-18):1310, 1312.
6
Severe leucopenia associated with Sitagliptin use.
Diabetes Res Clin Pract. 2011 Feb;91(2):e30-2. doi: 10.1016/j.diabres.2010.10.004. Epub 2010 Oct 29.
7
[Sitagliptin. Dipeptidylpeptidase 4 inhibitor for patients with diabetes mellitus type 2].
Med Monatsschr Pharm. 2007 Aug;30(8):282-6; quiz 287-8.
8
[Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?].
Dtsch Med Wochenschr. 2008 Oct;133(43):2233-7. doi: 10.1055/s-0028-1091266. Epub 2008 Oct 15.
9
10
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
Clin Pharmacol Ther. 2007 May;81(5):761-7. doi: 10.1038/sj.clpt.6100167. Epub 2007 Mar 28.
引用本文的文献
1
[Molecular tumour therapy: antibodies and small molecules].
Internist (Berl). 2008 May;49(5):581-92. doi: 10.1007/s00108-008-2096-x.
Zotero 插件